HER2 Support Group Forums - View Single Post - New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- meta

News · 03-07-2016, 06:31 AM

AstraZeneca today announced that the US Food and Drug Administration has approved a new indication in the US, expanding the use of Faslodex (fulvestrant) to include use in combination with Ibrance (palbociclib).

More...

03-07-2016, 06:31 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,103	New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- meta AstraZeneca today announced that the US Food and Drug Administration has approved a new indication in the US, expanding the use of Faslodex (fulvestrant) to include use in combination with Ibrance (palbociclib). More...